Welcome to Theralase®

For over 20 years, we have focused on the design, development, manufacture, and sale of patented laser technologies. 
Our superpulsed, dual-wavelength lasers are safe and effective, allowing your patients to start Healing at the Speed of Light®

Free Webinar - October 17, 2018

In this webinar, Dr. Elizabeth Angelevski, D.C., will discuss Alzheimer’s disease, Parkinson’s disease, and Multiple Sclerosis. Starting with an overview of
each condition, to current theories and research findings of transcranial LLLT for neurodegenerative disease.

We are Hiring!

We are expanding our team and have the following full time positions available immediately:
Marketing Coordinator, Public Relations Coordinator, Investor Relations Coordinator.

Anti-Cancer Research

We are a Canadian clinical stage pharmaceutical company dedicated to the research and development of light-activated
Photo Dynamic Compounds and their associated drug formulations to safely and effectively destroy cancer.  

Healing at the Speed of Light®

We also design, manufacture and distribute patented and proprietary super-pulsed cool laser technology
for the treatment of knee pain, and in off-label use, the treatment of numerous nerve, muscle and joint conditions.

Super-Pulsed Cool Laser Technology

With up to 4 probes, the versatile TLC-2000 series helps you treat multiple conditions at the same time, or
multiple patients simultaneously, enhancing productivity, growing revenue, and driving patient satisfaction.

Completed Phase 1b Clinical Study

Our laser systems have been used to treat over 1,000,000 patients worldwide, and our anti-cancer technology has now
successfully completed a Phase 1b Clinical Study for Non-Muscle Invasive Bladder Cancer ("NMIBC").  

Theralase® Technologies Inc. is a biopharmaceutical company headquartered in Toronto, Canada focused on the design, development, manufacturing, and sale of patented laser technology platforms used in a wide range of bio-stimulative and bio-destructive clinical applications in patients.

Founded in 1994, Theralase’s operations are divided into two divisions: the production of therapeutic laser technology for commercial applications, and the research and development of laser-based technologies for the destruction of cancer cells and other disease states.

Therapeutic Laser Technology Division

Theralase® focuses on the development of laser-based of laser-based non-invasive therapeutic devices to eliminate pain, reduce inflammation, and accelerate tissue healing.


Photo Dynamic Therapy Division 

Theralase® develops advanced pharmaceutical products and medical devices based on proprietary non-immunosuppressive photodynamic technology, targeting high anti-cancer effectiveness, microbial sterilization potency, and bacterial infection control.

As seen on..

Our Partners in Innovation